Profil
Brian Fenton is currently the Co-Chairman at MassBiologics since 1999.
He previously worked as the Executive Director-Business Development at Idenix Pharmaceuticals LLC from 2006 to 2011.
From 2015 to 2021, he worked as the Vice President-Corporate Development at Translate Bio, Inc. He also worked as the Head-Business Development at Shire Pharmaceuticals, Inc. Mr. Fenton received his undergraduate degree from the University of Massachusetts in 1989, his graduate degree from the University of Virginia in 1993, and his MBA from Worcester Polytechnic Institute in 2002.
Postes actifs de Brian Fenton
| Sociétés | Poste | Début |
|---|---|---|
MassBiologics
 MassBiologics BiotechnologyHealth Technology Part of University of Massachusetts, Inc., MassBiologics is a company that aims to improve public health by discovering and developing products. The company is based in Mattapan, MA. The company's focus is on creating products for smaller patient populations, uncertain markets, and developing nations with limited resources and unique needs. | Chairman | 01/01/1999 |
Anciens postes connus de Brian Fenton
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 14/09/2021 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2011 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | - |
Formation de Brian Fenton
| University of Virginia | Graduate Degree |
| University of Massachusetts | Undergraduate Degree |
| Worcester Polytechnic Institute | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
MassBiologics
MassBiologics BiotechnologyHealth Technology Part of University of Massachusetts, Inc., MassBiologics is a company that aims to improve public health by discovering and developing products. The company is based in Mattapan, MA. The company's focus is on creating products for smaller patient populations, uncertain markets, and developing nations with limited resources and unique needs. | Health Technology |
